COMPANY
About
Philosophy
History
Partners
Leadership
BUSINESS
Pipeline
Bacteriotherapy
Probiotics
R&D
Lab
Performance
Production Optimization Technology
PR
Public Relations
Careers
CONTACT
Notice
Online inquiry
Directions
KR
EN
메뉴닫기
COMPANY
About
Philosophy
History
Partners
Leadership
BUSINESS
Pipeline
Bacteriotherapy
Probiotics
R&D
Lab
Performance
Production Optimization Technology
PR
Public Relations
Careers
CONTACT
Notice
Online inquiry
Directions
KR
EN
메뉴보기
R&D
HealthBiome is going to contribute to the promotion of human
health through continuous research and development
HealthBiome is going to contribute
to the promotion of human health through
continuous research and development
Lab
Performance
Production Optimization Technology
Performance
메뉴열기
Lab
Performance
Production Optimization Technology
Human gut microbiome
Establishment of technology for pure separation and commercial mass
production of unculturable strict anaerobic microbes as LBP
Technology for candidate strain identification
Differentiation of strains
New species of the genus
Akkermansia
Ref. IJSEM 2004
New species of the genus
Ruminococcus
Butyrate production
New species of the genus
Bifidobacterium
19 probiotics approved by the MFDS
Establishment of pipeline for the treatment of 3 major incurable
diseases based on strict anaerobic microbiome
Anti-ageing, Brain disease, Anti-cancer treatment
Disease treatment, Preventive functional food, Medical food, Animal medicine & Health functional feed
Non-clinical/Clinical Progress
Development of disease treatment, new drugs for prevention & Release of prototype drug
Development of additional pipeline
Expanding indications such as Autism, Depression, Acne, Atopy, Arthritis, etc.